3 categories of volunteers ... two get real vaccinations and the third is "fake"
The third stage of the Corona vaccine achieves the first target
The diversity of the volunteers ’nationalities leads to the speed of achieving the goal. From the source
It achieved the first clinical trial in the world for the third phase of the inactive vaccine for the "Covid-19" virus, its first target, and reached more than 5,000 volunteers in clinical phase trials, representing 80 nationalities, which reflects the diversity and commitment of the entire community, while the Department of Health announced in Abu Dhabi on the possibility of using the volunteers in the third phase of the inactive "Covid-19" vaccine trials, to apply the fortress to identify themselves throughout the program period, as the volunteer fortification application will show the date of the vaccine dose (the first vaccine is white, and the second vaccine is golden). Noting that the new update is available on all "iOS" and "Android" devices.
In detail, the department confirmed that the experiments of the inactive vaccine for "Covid-19", as part of the campaign for humanity, exceeded 5,000 volunteers, considering it a prominent development of the first experiments in the world for the third phase of the inactive vaccine, and emphasizing the importance of the spirit of volunteering at the national level, And the strength of the health care system in achieving the desired goal.
The Acting Undersecretary of the Health Department, Dr. Jamal Al-Kaabi, said, “The volunteers were distributed into three categories, of which two groups will receive a real vaccination, and the third will receive a placebo vaccine, and the volunteers will be monitored during the study phase and comparisons are made,” stressing that the vaccination is safe. This matter was audited in the first and second stages, and accordingly it was approved to move to the third stage, and an increase in the concern for the safety of volunteers was followed up daily to check for any symptoms.
He added that «the country has 200 nationalities, and the invitation to volunteer is open to all, citizens and residents, and citizens and residents who wish to volunteer can go directly to the field clinic at the Abu Dhabi Exhibition Center (ADNEC) without the need to register on the site or call, all days of the week. Noting that the demand for volunteering in the third phase of clinical trials of the inactive "Covid-19" vaccine is constantly increasing by citizens or residents.
He pointed out that the process of registering and obtaining vaccination for the first visit at the exhibition center in Abu Dhabi takes from two to four hours, according to the number of volunteers present at that time, pointing to the importance of community members' participation in clinical trials, especially as the world is waiting for the results of this experiment.
He continued: “If the clinical trials of the third phase of the inactivated (Covid-19) virus, which we are working on now, are successful, the good news will be issued from the Emirates, so the participation of community members is important, and the participants do not know who of them got the real vaccination, "Whoever received the placebo vaccine, and in the event that the tests were successful, priority will be given to obtaining vaccination for the volunteers who received the placebo vaccine, in appreciation of their participation in the experiments."
For its part, the Infectious Diseases Consultant, Head of the Clinical Executive Committee for Coronavirus, Executive Director of Medical Affairs of Sheikh Khalifa Medical City, Dr. Nawal Al-Kaabi, stated that the entry of clinical trials of the inactive Corona vaccine in the second target, and reaching the required number, to close the study of 15 thousand volunteers, Noting that they follow the volunteers, on a permanent basis, and conduct blood tests to determine the effectiveness of the vaccination and discover any cases of corona infection among the volunteers, to put it under observation.
While the authorities responsible for registering, examining and testing volunteers participating in the third clinical trial, the Department of Health Abu Dhabi, the "G42 Healthcare" and "SEHA", have identified nine stages for the volunteer's participation, obtaining the vaccine and its follow-up, including explaining the contents of the volunteer's clinical study, and obtaining informed consent And volunteer registration.
She added that the attending physician conducts a physical examination, and medical examinations that include measuring body temperature, measuring height and weight, blood pressure and blood sugar level, hearing the heart and lungs, examining the skin and throat, and others, and making a swab to detect the virus, and conducting a urine pregnancy test for volunteers from Women of childbearing age.
She added that the rest of the stages are completed if the volunteer is ready to participate, as he is included as a participant in the study in a random pattern, gets an identification number, and takes 12.5 ml of venous blood for an antibody test, after which the volunteer is given the vaccine or placebo drug developed by the company. Direct interactions will be followed up for 30 minutes after the volunteer received the vaccination inside the place of study, and then they will be followed up by phone within six to 24 hours, after each dose of the vaccine, a personal follow-up visit within three days, and a follow-up procedure over the phone (from 4 to 7 days), to inquire about the occurrence of any side effects, and to follow up on filling out the daily notes card for vaccination, as follow-up will continue for 12 months from the date of getting the first dose.
7 contraindications for participation
The authorities responsible for the third clinical trial of the inactive Covid-19 virus, the Department of Health, the G42 Healthcare Company and the (SEHA), have identified seven barriers to participating in volunteering clinical trials for the third phase of the Corona vaccination test and receiving The vaccine.
Contraindications include symptoms such as: fever, cough, dehydration, fatigue, runny nose or nasal congestion, during the 14 days preceding the vaccination, and the presence of an allergy to some medicines for the person wishing to volunteer or one of his family members.
It also includes the presence of pre-existing infections of convulsion or epilepsy, or any acute or chronic diseases, such as asthma, cardiovascular disease, liver and kidney disease, and malignant tumors, receiving any immunosuppressive treatment, and exposure to blood transfusion within three months before vaccination, in addition to preventing the participation of pregnant women Or wanting to become pregnant during the trial period.
The world is waiting for the results of the third phase trials of the "Covid-19" vaccine.